Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer. | Cell Rep Med | 2023 | 36921601 | PubTator, text mining | PubMed |
| Primary breast mucinous cystadenocarcinoma-histopathological analysis. | Transl Cancer Res | 2023 | 36915580 | PubTator, text mining | PubMed |
| Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer. | Cancer Med | 2023 | 36912150 | PubTator, text mining | PubMed |
| Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene. | Front Oncol | 2023 | 36910630 | PubTator, text mining | PubMed |
| Hereditary cancer syndromes. | World J Clin Oncol | 2023 | 36908677 | PubTator, text mining | PubMed |
| Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. | Eur J Cancer Prev | 2023 | 36896836 | PubTator, text mining | PubMed |
| ARID1A in cancer: Friend or foe? | Front Oncol | 2023 | 36890819 | PubTator, text mining | PubMed |
| RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway. | Ann Clin Lab Sci | 2023 | 36889779 | PubTator, text mining | PubMed |
| Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression. | BMC Cancer | 2023 | 36882706 | PubTator, text mining | PubMed |
| LncRNA and its role in gastric cancer immunotherapy. | Front Cell Dev Biol | 2023 | 36875764 | PubTator, text mining | PubMed |
| Strategies for Conditional Regulation of Proteins. | JACS Au | 2023 | 36873677 | PubTator, text mining | PubMed |
| Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence. | BMC Med Genomics | 2023 | 36872334 | PubTator, text mining | PubMed |
| Microsatellite instability assessment is instrumental for Predictive, Preventive and Personalised Medicine: status quo and outlook. | EPMA J | 2023 | 36866160 | PubTator, text mining | PubMed |
| Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers. | Eur J Pharmacol | 2023 | 36858339 | PubTator, text mining | PubMed |
| Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma. | iScience | 2023 | 36852159 | PubTator, text mining | PubMed |
| Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses. | World J Surg Oncol | 2023 | 36849965 | PubTator, text mining | PubMed |
| Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian Cancer. | J Pharmacol Exp Ther | 2023 | 36849411 | PubTator, text mining | PubMed |
| Disturbed flow increases endothelial inflammation and permeability via a Frizzled-4-β-catenin-dependent pathway. | J Cell Sci | 2023 | 36846872 | PubTator, text mining | PubMed |
| TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer. | Front Oncol | 2023 | 36845719 | PubTator, text mining | PubMed |
| Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments. | World J Gastroenterol | 2023 | 36844139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=21